Hostname: page-component-78c5997874-t5tsf Total loading time: 0 Render date: 2024-11-14T23:04:34.856Z Has data issue: false hasContentIssue false

Cardiac manifestations and short-term outcomes of multisystem inflammatory syndrome in Middle Eastern children during the COVID-19 pandemic: a case series

Published online by Cambridge University Press:  17 June 2021

Theresia E. Tannoury
Affiliation:
Children’s Heart Center, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Ziad R. Bulbul*
Affiliation:
Children’s Heart Center, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
Fadi F. Bitar
Affiliation:
Children’s Heart Center, Department of Pediatrics and Adolescent Medicine, American University of Beirut Medical Center, Beirut, Lebanon
*
Author for correspondence: Dr Z. Bulbul, MD, Department of Pediatrics and Adolescent Medicine, American University of Beirut, PO Box 11-0236, Riad-El Solh St., Beirut, 1107 2020, Lebanon. Tel: +9 617 679 3838; Fax: +961370781. E-mail: ziad.bulbul@abu.edu.lb.

Abstract

We herein report on a series of four patients presented to our tertiary care centre with features of multisystem inflammatory syndrome in children and cardiac involvement. Two of our patients had recent exposure to a COVID-19-positive patient, one had recent documented infection, and another had no known positive contact. All the patients were tested positive for severe acute respiratory syndrome coronavirus 2 immunoglobulin G antibody at the time of presentation. All of them fulfilled the diagnostic criteria according to the World Health Organization Centers for Disease Control or the British guidelines for MIS-C (fever for ≥3 days, multisystem involvement (at least two), elevated markers of inflammation, and no other alternative diagnosis).

Cardiac involvement was variable ranging from isolated ectasia of the coronary arteries to full-blown pancarditis such as severe biventricular dysfunction, multi-valvar involvement, and pericardial effusion.

All our patients received intravenous immunoglobulin (2 g/kg), methylprednisolone, and aspirin and some required inotropic support and ICU admission.

Remarkably, all our patients showed significant improvement in their cardiac disease within a few days as evident on serial echocardiographic evaluation. However, we stress the need for long-term follow-up as one of our patients demonstrated mild LV myocardial scarring as evident by gadolinium late enhancement on a cardiac MRI.

Type
Brief Report
Copyright
© The Author(s), 2021. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Rabinowicz, S, Leshem, E, Pessach, IM. COVID-19 in the pediatric population-review and current evidence. Curr Infect Dis Rep 2020; 22: 29.10.1007/s11908-020-00739-6CrossRefGoogle ScholarPubMed
World Health Organization. Multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19, 2020. Retrieved May 15, 2020, from https://www.who.int/news-room/commentaries/detail/multisystem-inflammatory-syndrome-in-children-and-adolescents-with-covid-19 Google Scholar
Narayanan, SN, Ahamed, MZ, Safia, M, et al. Cardiovascular involvement in Kawasaki disease. Indian Pediatr 2005; 42: 918922.Google ScholarPubMed
Feldstein, LR, Rose, EB, Horwitz, SM, et al. Multisystem inflammatory syndrome in U.S. children and adolescents. N Engl J Med 2020; 383: 334346.CrossRefGoogle ScholarPubMed
Davies, P, Evans, C, Kanthimathinathan, HK, et al. Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicenter observational study. Lancet Child Adolesc Health 2020; 4: 669677.10.1016/S2352-4642(20)30215-7CrossRefGoogle Scholar
Almoosa, ZA, Al Ameer, HH, AlKadhem, SM, et al. Multisystem inflammatory syndrome in children, the real disease of COVID-19 in pediatrics – a multicenter case series from Al-Ahsa, Saudi Arabia. Cureus 2020; 12: e11064.Google Scholar
Kaushik, S, Aydin, SI, Derespina, KR, et al. Multisystem inflammatory syndrome in children associated with severe acute respiratory syndrome coronavirus 2 infection (MIS-C): a multi-institutional study from New York City. J Pediatr 2020; 224: 2429.10.1016/j.jpeds.2020.06.045CrossRefGoogle ScholarPubMed
Chiotos, K, Bassiri, H, Behrens, EM, et al. Multisystem inflammatory syndrome in children during the coronavirus 2019 pandemic: a case series. J Pediatric Infect Dis Soc 2020; 9: 393398.10.1093/jpids/piaa069CrossRefGoogle ScholarPubMed
Tops, LF, Delgado, V, Marsan, NA, Bax, JJ. Myocardial strain to detect subtle left ventricular systolic dysfunction. Eur J Heart Fail 2017; 19: 307313.10.1002/ejhf.694CrossRefGoogle ScholarPubMed
Moran, AM, Newburger, JW, Sanders, SP, et al. Abnormal myocardial mechanics in Kawasaki disease: rapid response to gamma-globulin. Am Heart J 2000; 139 (Pt 1): 217223.Google ScholarPubMed
Blondiaux, E, Parisot, P, Redheuil, A, et al. Cardiac MRI in children with multisystem inflammatory syndrome associated with COVID-19. Radiology 2020; 297: E283E288.CrossRefGoogle ScholarPubMed
Bratis, K, Hachmann, P, Child, N, et al. Cardiac magnetic resonance feature tracking in Kawasaki disease convalescence. Ann Pediatr Cardiol 2017; 10: 1825.10.4103/0974-2069.197046CrossRefGoogle ScholarPubMed
Sperotto, F, et al. Cardiac manifestations in SARS-CoV-2-associated multisystem inflammatory syndrome in children: a comprehensive review and proposed clinical approach. Eur J Pediatr 2021; 180: 307322.10.1007/s00431-020-03766-6CrossRefGoogle ScholarPubMed